Immunomedics, Inc. Gains 99.79%

Mon 06 Apr 20 at 05:30 PM
Immunomedics, Inc. Gains 99.79%

Immunomedics, Inc. (IMMU:NASDAQ) soared at $18.78, representing a gain of 99.8%. On Fri 03 Apr 20, IMMU:NASDAQ touched a New 2-Week Low of $9.4. The stock got featured on our News Catalysts scanner on Fri 03 Apr 20 at 06:57 PM in the 'BIOTECH' category. From Fri 20 Mar 20, the stock recorded 50.00% Up Days and 63.64% Green Days

About Immunomedics, Inc. (IMMU:NASDAQ)

Immunomedics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.